New technology achieves world-leading accuracy while significantly extending video duration processing capability
Dec 18, 2024
HANGZHOU,China,Dec. 12,2024-- In the heart ofHangzhou,Liangzhu Ancient City,which boasts rich cultural heritage,stands as a testament to a sophisticated 5,000-year-old civilization. At the 2nd Liangzh
Dec 18, 2024
HONG KONG,Dec. 12,2024-- On December 12th and 13th,the 2024 China Mermaid Open Grand Final and Asian Cup commenced grandly at AtlantisSanya. As the first Asian Cup for mermaid sports,this event marks
Dec 18, 2024
IFS Cloud will help the international provider of vitalizing workspaces gain real-time insights,accelerate new business initiatives,and meet ESG targets
Dec 18, 2024
SK bioscience\'s first mRNA vaccine candidate is expected to enter clinical trials in Australia in February 2025,with interim results expected by 2026.
Dec 18, 2024
BEIJING,Dec. 12,2024--The city of Shanghai is a first choice for many foreign tourists to learn about China. Join us in a video tour to Minhang District in Shanghai and explore the charm of intangible
Dec 18, 2024
ARMONK,N.Y.,Dec. 13,2024-- The IBM (NYSE: IBM) Institute for Business Value today published its latest \'Automotive 2035\' study which reveals an industry grappling with an erratic transition away fro
Dec 18, 2024
TAIPEI,Dec. 12,2024-- VIVOTEK (3454-TW),the global leading security solution provider,continues to demonstrate exceptional capabilities by securing the 14th spot in the 2024 Security 50,remaining the
Dec 18, 2024
LONDON,Dec. 12,2024-- Avature,a leading provider of Human Capital Management (HCM) software for recruiting and talent management,has picked up two golds at this year\'s prestigious Brandon Hall Excel
Dec 18, 2024
HONG KONG,Dec. 12,2024-- Sino Jet is delighted to announce that it has unveiled a major strategic initiative at the Middle East and North Africa Business Aviation Association (MEBAA) exhibition 2024
Dec 18, 2024
TheGlobal X US Treasury 0-3 Month ETF (3440 / 9440)is the first short-term US T-bills ETF listed in Hong Kong
Dec 18, 2024
SUZHOU,China,Dec. 13,2024-- Alphamab Oncology (stock code: 9966.HK) announced that the latest clinical data from a phase II clinical study on PD-L1/CTLA-4 bispecific antibody KN046 in combination with
Dec 18, 2024

© TopicFashion Privacy Policy Contact us